C Tham

5.0k total citations · 2 hit papers
18 papers, 2.1k citations indexed

About

C Tham is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, C Tham has authored 18 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 10 papers in Infectious Diseases and 6 papers in Hepatology. Recurrent topics in C Tham's work include Hepatitis B Virus Studies (8 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and Hepatitis C virus research (6 papers). C Tham is often cited by papers focused on Hepatitis B Virus Studies (8 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and Hepatitis C virus research (6 papers). C Tham collaborates with scholars based in Singapore, Italy and Germany. C Tham's co-authors include Antonio Bertoletti, Anthony T. Tan, Jenny G. Low, Shirin Kalimuddin, Adeline Chia, Nina Le Bert, Lin‐Fa Wang, Martin Linster, Wan Ni Chia and Kamini Kunasegaran and has published in prestigious journals such as Nature, Gastroenterology and Journal of Virology.

In The Last Decade

C Tham

16 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls

2020 1.2k citations Nina Le Bert, Anthony T. Tan et al. Nature profile →
Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients

2021 440 citations Anthony T. Tan, Martin Linster et al. Cell Reports profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C Tham Singapore	12	1.7k	501	409	396	272	18	2.1k
Kamini Kunasegaran Singapore	11	1.6k 0.9×	504 1.0×	427 1.0×	379 1.0×	336 1.2×	17	2.1k
Nina Le Bert Singapore	23	2.2k 1.3×	1.1k 2.2×	706 1.7×	458 1.2×	720 2.6×	42	3.4k
Carolyn Rydyznski Moderbacher United States	5	2.5k 1.4×	695 1.4×	581 1.4×	567 1.4×	160 0.6×	5	2.8k
Meiyin Lin Singapore	4	1.1k 0.6×	307 0.6×	263 0.6×	263 0.7×	67 0.2×	6	1.3k
Daniel Marrama United States	6	2.0k 1.2×	537 1.1×	465 1.1×	512 1.3×	126 0.5×	6	2.3k
Aaron Sutherland United States	8	2.0k 1.2×	545 1.1×	467 1.1×	524 1.3×	144 0.5×	14	2.4k
Manish Sagar United States	23	1.4k 0.8×	549 1.1×	355 0.9×	97 0.2×	477 1.8×	69	2.3k
Daniel Stadlbauer United States	18	1.4k 0.8×	422 0.8×	285 0.7×	161 0.4×	733 2.7×	31	2.1k
Tania Garron United States	12	1.2k 0.7×	220 0.4×	221 0.5×	93 0.2×	274 1.0×	18	1.4k

Countries citing papers authored by C Tham

Since Specialization

Citations

This map shows the geographic impact of C Tham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Tham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Tham more than expected).

Fields of papers citing papers by C Tham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Tham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Tham. The network helps show where C Tham may publish in the future.

Co-authorship network of co-authors of C Tham

This figure shows the co-authorship network connecting the top 25 collaborators of C Tham. A scholar is included among the top collaborators of C Tham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Tham. C Tham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Ong, Eugenia Z., Jia Xin Yee, Justin S. G. Ooi, et al.. (2025). Dengue virus infection reprograms baseline innate immune gene expression. Med. 6(11). 100841–100841.

Mok, Darren Z. L., Jia Xin Yee, C Tham, et al.. (2024). Electron transport chain capacity expands yellow fever vaccine immunogenicity. EMBO Molecular Medicine. 16(6). 1310–1323. 1 indexed citations

Syenina, Ayesa, Esther S. Gan, Ruklanthi de Alwis, et al.. (2022). Adverse effects following anti–COVID-19 vaccination with mRNA-based BNT162b2 are alleviated by altering the route of administration and correlate with baseline enrichment of T and NK cell genes. PLoS Biology. 20(5). e3001643–e3001643. 29 indexed citations

Tan, Anthony T., Martin Linster, Chee Wah Tan, et al.. (2021). Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients. Cell Reports. 34(6). 108728–108728. 440 indexed citations breakdown →

Kalimuddin, Shirin, C Tham, Martin Qui, et al.. (2021). Early T cell and binding antibody responses are associated with COVID-19 RNA vaccine efficacy onset. Med. 2(6). 682–688.e4. 103 indexed citations

Loglio, Alessandro, Péter Ferenci, Sara Uceda Renteria, et al.. (2021). Safety and effectiveness of up to 3 years’ bulevirtide monotherapy in patients with HDV-related cirrhosis. Journal of Hepatology. 76(2). 464–469. 48 indexed citations

Tan, Cedric, C. J. Owen, C Tham, et al.. (2021). Pre-existing T cell-mediated cross-reactivity to SARS-CoV-2 cannot solely be explained by prior exposure to endemic human coronaviruses. Infection Genetics and Evolution. 95. 105075–105075. 35 indexed citations

Kalimuddin, Shirin, C Tham, Martin Qui, et al.. (2021). Early T Cell and Binding Antibody Responses are Associated with COVID-19 RNA Vaccine Efficacy Onset. SSRN Electronic Journal. 22 indexed citations

Bert, Nina Le, Anthony T. Tan, Kamini Kunasegaran, et al.. (2020). SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature. 584(7821). 457–462. 1224 indexed citations breakdown →

10.

Tham, C, Janine Kah, Anthony T. Tan, et al.. (2020). Hepatitis Delta Virus Acts as an Immunogenic Adjuvant in Hepatitis B Virus-Infected Hepatocytes. Cell Reports Medicine. 1(4). 100060–100060. 21 indexed citations

11.

Loglio, Alessandro, Péter Ferenci, C Tham, et al.. (2020). Safety and efficacy of up to 76 weeks 10 mg/day (high dose) bulevirtide monotherapy in compensated cirrhotics with delta hepatitis. Digestive and Liver Disease. 52. e28–e29. 1 indexed citations

12.

Tham, C, Anthony T. Tan, Janine Kah, et al.. (2020). Hepatitis Delta Virus Infection Increases the Efficacy of HBV-Specific T Cell-Based Therapies. SSRN Electronic Journal. 1 indexed citations

13.

Loglio, Alessandro, Péter Ferenci, Sara Uceda Renteria, et al.. (2019). Excellent safety and effectiveness of high-dose myrcludex-B monotherapy administered for 48 weeks in HDV-related compensated cirrhosis: A case report of 3 patients. Journal of Hepatology. 71(4). 834–839. 47 indexed citations

14.

Loglio, Alessandro, A. A. Alexandrov, Sara Uceda Renteria, et al.. (2019). Effectiveness, safety and T-cell activation profiles of long-term Myrcludex B treatment in two patients with HDV related compensated cirrhosis. Digestive and Liver Disease. 51. e62–e62.

15.

Koh, Sarene, Janine Kah, C Tham, et al.. (2018). Nonlytic Lymphocytes Engineered to Express Virus-Specific T-Cell Receptors Limit HBV Infection by Activating APOBEC3. Gastroenterology. 155(1). 180–193.e6. 58 indexed citations

16.

Wijaya, Limin, et al.. (2017). An accelerated rabies vaccine schedule based on toll-like receptor 3 (TLR3) agonist PIKA adjuvant augments rabies virus specific antibody and T cell response in healthy adult volunteers. Vaccine. 35(8). 1175–1183. 27 indexed citations

17.

Koh, Sarene, et al.. (2015). G04 : Engineered HBV-specific T cells: Disentangling antiviral from killing capacity. Journal of Hepatology. 62. S188–S188. 8 indexed citations

18.

Tan, Anthony T., Pimpayao Sodsai, Adeline Chia, et al.. (2013). Immunoprevalence and Immunodominance of HLA-Cw∗0801-Restricted T Cell Response Targeting the Hepatitis B Virus Envelope Transmembrane Region. Journal of Virology. 88(2). 1332–1341. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact